GE Showcases Revolution CT
GE to showcase at RSNA 2014 its Revolution family of CT scanners.
GE Healthcare will showcase at RSNA 2014 the Revolution family of CT scanners.
Revolution CT was launched at RSNA 2013, and since then, the Revolution family has grown to include Revolution GSI, Revolution HD, and Revolution EVO. The Revolution family is built on the core technologies of image quality, ultra-low dose, speed, and simplicity, GE said.
Revolution GSI uses gemstone spectral imaging, which enables customers to accomplish quantitative tissue characterization and advanced functional imaging for quantitative information, GE said.
Revolution HD provides low dose, high definition image quality.
Revolution EVO is a new CT made for institutions that are unable to sacrifice advanced capabilities like high resolution for daily productivity, GE said.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
